Yet another coronavirus vaccine prospect has proven promising final results in a Period 1/2 demo executed in the US. An mRNA experimental drug produced by BioNTech, which partnered with Pfizer for the growth of the drug, proved it can produce the neutralizing antibodies that would be equipped to block the coronavirus and avoid infection. In accordance to the details the two organizations released, together with the whole research for the clinical trial, various doses of…

Pin It